There are 12 papers on cancer risk in aging research: 6 observational studies in people, 5 reviews.
12 papers study it2,429 more mention it18 findings
221 new papers in 30 daysSee all 2,441 papers on cancer risk
At a glance
Higher DNA methylation-based biological age and GrimAge are linked with higher cancer risk in a human study. Human studies also link CHEK2 protein-truncating variants with higher risk and RTEL1 missense variants with lower risk. Smoking cessation is associated with lower cancer risk, as is exercise among smokers.
18 findings in 12 papers from 2019 to 2026, 3 of them since August 2026
“the presence of at least one CHEK2 pLoF variant was associated with increased odds of diagnosis with 14 different cancers (odds ratio [OR] range: 1.34-3.21).”
- Humans6
- In silico1
Upstream
2ATXN2
no changein humans1
1 study
ATXN2
no changein humans1
ATXN2 was not clearly linked with cancer risk in humans (CAG repeat size in patients with Parkinson's disease).
“No association was observed between CAG size in the HTT and ATXN2 genes and risk of cancer in patients with Parkinson's disease.”
HumansCAG repeat size in patients with Parkinson's disease
Brain communications
HTT
no changein humans1
1 study
HTT
no changein humans1
HTT was not clearly linked with cancer risk in humans (CAG repeat size in patients with Parkinson's disease).
“No association was observed between CAG size in the HTT and ATXN2 genes and risk of cancer in patients with Parkinson's disease.”
HumansCAG repeat size in patients with Parkinson's disease
Brain communications
Associations
16Microbiome composition
upin humans1
1 study
Microbiome composition
upin humans1
Microbiome composition is associated with cancer risk in humans.
“Prospective cohort studies, with faecal samples collected before a cancer diagnosis, will be instrumental in assessing the role of the gut microbiome in human cancer risk.”
Review
The Lancet. Microbe
Exercise
downin humans1
1 study
Exercise
downin humans1
Exercise is linked with a lower risk of cancer risk in smokers.
“participants with favorable behaviors (e.g., regular physical activity and healthier diet) generally had lower ERRs/pack-year than those with unfavorable behaviors”
Humansin smokersn = 500,000
Smoking patterns linked to cancer risk beyond total exposure
MedScience
Smoking cessation
downin humans1
1 study
Smoking cessation
downin humans1
Smoking cessation is linked with a lower risk of cancer risk in humans.
“longer TSC was associated with lower ERR/pack-year for most cancers”
Humansn = 500,000
Smoking patterns linked to cancer risk beyond total exposure
MedScience
RTEL1
downin humans1
1 study
RTEL1
downin humans1
RTEL1 is linked with a lower risk of cancer risk in humans (presence of at least one RTEL1 missense variant) (OR range: 0.67-0.88).
“the presence of at least one RTEL1 missense variant was associated with lower odds of diagnosis with 9 cancers (OR range: 0.67-0.88).”
Humanspresence of at least one RTEL1 missense variant
The pleiotropic landscape of rare variant associations with multiple cancers in large biobanks
HGG advances
CHEK2
upin humans1
1 study
CHEK2
upin humans1
CHEK2 is linked with a higher risk of cancer risk in humans (presence of at least one CHEK2 pLoF variant) (OR range: 1.34-3.21).
“the presence of at least one CHEK2 pLoF variant was associated with increased odds of diagnosis with 14 different cancers (odds ratio [OR] range: 1.34-3.21).”
Humanspresence of at least one CHEK2 pLoF variant
The pleiotropic landscape of rare variant associations with multiple cancers in large biobanks
HGG advances
DNA methylation-based biological age
upin humans1
1 study
DNA methylation-based biological age
upin humans1
DNA methylation-based biological age predicts cancer risk in humans (33% to 37% higher risk per SD increase).
“corresponding to a 33% to 37% higher risk per SD increase in slopes of four BA matrices”
Humans
Epigenetic aging and cancer incidence in a German cohort of older adults
npj aging
GrimAge
upin humans1HR 1.67
1 study
GrimAge
upin humans1HR 1.67
GrimAge predicts cancer risk in humans (HR 1.67 (95% CI 1.25-2.24)).
“hazard ratios up to 1.67 (95% CI 1.25-2.24) per standard deviation (SD) increase in PCGrimAge”
Humans
Epigenetic aging and cancer incidence in a German cohort of older adults
npj aging
PUFA-related autoencoder component
mixedin humans1
1 study
PUFA-related autoencoder component
mixedin humans1
PUFA-related autoencoder component is associated with cancer risk in humans (Compared with PCA.1).
“AEs decomposed PC metabolism into two components, one of which exhibited a stronger association with cancer risk than PCA.1.”
HumansCompared with PCA.1
EBioMedicine
Somatic mutations
upin silico1
1 study
Somatic mutations
upin silico1
somatic mutations raise the risk of cancer risk in silico.
“mutations that most strongly increase cancer risk are enriched in younger patients' cancers”
In silico
Age distinguishes selection from causation in cancer genomes
bioRxiv : the preprint server for biologyPreprint
Vitamin D
downin humans1
1 study
Vitamin D
downin humans1
Vitamin D lowers the risk of cancer risk in humans (levels above 40 ng/mL) (>40 ng/mL (100 nmol/L: range, 40-80 ng/mL)).
“maintaining levels above 40 ng/mL (100 nmol/L: range, 40-80 ng/mL) significantly lowers cancer risks and mortality”
Reviewlevels above 40 ng/mL
Vitamin D's Impact on Cancer Incidence and Mortality: A Systematic Review
Nutrients
All 16Fewer
Trial sponsors
University of California, San Francisco
1 trial400 people
Funding
200 grants since 2016National Cancer Institute$176MNational Institute of Environmental Health Sciences$18.2MGouvernement du Canada | Canadian Institutes of Health ResearchCA$3M
American Cancer SocietyDartmouth College150K2026–2027
Salpingectomy for Ovarian Cancer Risk Reduction: Improving Utilization and Informed Decision-Making
Agency for Healthcare Research and QualityColumbia University Health Sciences$355K2022–2027
Helicobacter Infection and Liver Cancer Risk among African Americans and Whites in the United States
National Cancer InstituteYale University$388K2021–2028
GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management
National Cancer InstituteUniversity of Utah$929K2023–2028
Latin America Genomics of Breast Cancer Risk Study (LAGENO-BCR)
National Cancer InstituteUniversity of California at Davis$6.5K2024–2029
National Cancer InstituteThe Netherlands Cancer Institute$62.4K2024–2027
National Cancer InstituteYale University$155K2026–2028
Identification of proteins for breast cancer risk: an integrative epidemiologic and genomic study
National Cancer InstituteVanderbilt University Medical Center$2.1M2024–2029
Metabolic Dysregulation and Cancer Risk Program: Coordinating Center
National Cancer InstituteGeorge Washington University$849K2022–2027
Building lung cancer risk prediction models for former smokers: An omics-based epidemiologic study
National Cancer InstituteVanderbilt University Medical Center$724K2026–2031
How this record changed
Summary rewritten as its findings changed.
As it read before
A human study links higher DNA methylation-based biological age and GrimAge with higher cancer risk. Reviews also describe cancer-risk prediction by epigenetic aging measures. Human observational studies associate smoking cessation with lower cancer risk, exercise with lower risk in smokers, and CHEK2 pLoF variants with higher risk.
Summary rewritten as its findings changed.
As it read before
A human study links higher DNA methylation-based biological age and GrimAge with higher cancer risk. Another associates smoking cessation with lower risk, and exercise with lower risk in smokers. A human genetic study links predicted loss-of-function CHEK2 variants with higher risk and RTEL1 missense variants with lower risk.
Summary rewritten as its findings changed.
As it read before
DNA methylation-based biological age, including GrimAge, predicts higher cancer risk in a human study; reviews also describe links between epigenetic aging and cancer risk. A human study associates CHEK2 predicted loss-of-function variants with higher risk and RTEL1 missense variants with lower risk. Another observational study links smoking cessation, and exercise among smokers, with lower cancer risk.
Summary rewritten as its findings changed.
As it read before
In human studies, DNA methylation-based biological age and GrimAge predict cancer risk. Carrying at least one CHEK2 pLoF variant is associated with higher risk, whereas carrying at least one RTEL1 missense variant is associated with lower risk. Smoking cessation, and exercise among smokers, are associated with lower risk.
Summary rewritten as its findings changed.
As it read before
Human studies associate CHEK2 pLoF variants with increased cancer risk and RTEL1 missense variants with reduced risk. Smoking cessation is linked to reduced risk, as is exercise in smokers; reviews describe an association between microbiome composition and cancer risk.